DA Davidson raised the firm’s price target on Matrix Service (MTRX) to $20 from $18 and keeps a Buy rating on the shares after its Q2 earnings beat. Despite the shift in some revenue this year, the ...
Researchers at Children's Hospital Los Angeles have discovered a key difference between the two main types of rhabdomyosarcoma—paving the way for more targeted treatments. The study, led by JinSeok ...